Could be sponsored by drug companies

BMJ 1995; 310 doi: 10.1136/bmj.310.6980.661 (Published 11 March 1995)
Cite this as: BMJ 1995;310:661.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. David Berger
  1. Senior house officer in medicine Royal Marsden Hospital, London SW3 6JJ

    EDITOR,—The prospect that the BMJ is even considering abandoning obituaries is too much.1 I am certain that a vast number of readers turn to the obituaries before reading anything else in the journal; this is definitely true among my friends and contemporaries (I graduated in 1991). The obituaries are truly fascinating, and, paradoxically, it is not those of the great and the good that are most interesting but …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL